High Grade Serous Ovarian
specific16
Centers
0
Active Trials
$47M
Cancer Funding
Top Centers for High Grade Serous Ovarian(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 69.5 |
| 2 | NCI Comprehensive Active Research Program | 67.3 |
| 3 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 65.2 |
| 4 | Mount Sinai Tisch Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 63.0 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 60.8 |
| 6 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.6 |
| 7 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 56.4 |
| 8 | NCI Comprehensive Active Research Program | 54.2 |
| 9 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 52.0 |
| 10 | NCI Comprehensive Active Research Program | 49.8 |
| 11 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 47.7 |
| 12 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 45.5 |
| 13 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 43.3 |
| 14 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 41.1 |
| 15 | Ellen and Ronald Caplan Cancer Center of The Wistar InstitutePhiladelphia, PA NCI Basic_laboratory Active Research Program | 38.9 |
| 16 | University of Illinois Cancer CenterChicago, IL | 36.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →